Article Per Year (5 Year)
p-Index From 2020 - 2025
0.23
P-Index
This Author published in this journals
All Journal Jurnal Farmasi Klinik - Best Practice (JFKlin)
Setiadi Darmawan, Bobby
Unknown Affiliation
Chemistry Health Professions Immunology & microbiology Medicine & Pharmacology Public Health

Published : 1 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 1 Documents
Search

 1 
Evaluation Of The Use Of Cyclophosphamide In Children Diagnosed With Steroid Resistant Nephrotic Syndrome Treated In The 3rd Floor Treatment At Fatmawati Hospital Sinukaban, Satriani; Setiadi Darmawan, Bobby
Jurnal Farmasi Klinik Best Practice Vol 1 No 1 (2022): Jurnal Farmasi Klinik - Best Practice
Publisher : RSUP Fatmawati

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.58815/jfklin.v1i1.14

Abstract

A total of 32 children with nephrotic syndrome were treated with cyclophosphamide, the remissions and side effects that often occurred during therapy were counted. This research was conducted using a retrospective descriptive method. The results showed that the remission was 59.4%. The mean duration of the call to remission was 14 weeks and the mean dose of cyclophosphamide was 589 mg. As many as 59.4% of patients experienced no side effects, while 40.6% experienced side effects. Side effects that occurred included vomiting (3.1%); nausea (3.1%); hair loss (6.3%); nausea and vomiting (12.5%); vomiting and hair loss (6.3%); nausea and hair loss (6.3%); and nausea, vomiting, and hair loss (3.1%). Keywords: Steroid-Resistant Nephrotic Syndrome, Cyclophosphamide
Co-Authors Sinukaban, Satriani